Strictly speaking, the Food and Drug Administration never recalls a dangerous food, drug, medical device, or other product. Technically, the FDA recommends a recall.<\/p>\n
The 2020 Recall Unsafe Drugs Act<\/a> would give the agency that power. As expected, drug companies and other such companies immediately opposed the bill.<\/p>\n Additionally, an official recall does nothing to compensate injury victims, and the responsible company simply walks away. These victims need compensation, and they deserve justice.<\/p>\n A New York personal injury attorney<\/a> can help provide these things. Available compensatory damages usually include money for economic losses, such as medical bills, and noneconomic losses, such as pain and suffering.<\/p>\n Justice comes in the form of additional punitive damages. These damages hit reckless companies where it hurts them most.<\/p>\n During new product development or existing product manufacturing, the FDA usually doesn\u2019t take a hands-on approach. Instead, this agency usually relies on the information the manufacturers give it.<\/p>\n Industry user fees account for almost half<\/a> of the FDA\u2019s budget. In other words, the more medical, food, and other products approved, the more money the agency makes.<\/p>\n Therefore, it\u2019s not surprising that some dangerous products slip through the cracks. These dangerous products usually include:<\/p>\n Sometimes, companies are completely blindsided by these problems, and they quickly do the right thing.<\/p>\n Generally, however, companies suppress negative information as long as possible.<\/p>\n They only take adverse action when they are cornered. Our New York product liability attorneys can usually obtain punitive damages in the latter situations.<\/p>\n Normally, the FDA initiates the recall recommendation process because it receives reports of adverse issues. These issues could be actual or potential injuries.<\/p>\n Health Hazard Evaluation<\/p>\n Initially, the FDA sets up a meeting. A team of scientists gets together to determine things like:<\/p>\n Technically, the drug company or other product maker does not have a voice during a health hazard evaluation.<\/p>\n After this team considers all these things and issues a report, the FDA decides on the appropriate recall classification. The categories are:<\/p>\n The FDA notifies the manufacturer of the health hazard evaluation and recall assessment. The next step is up to the manufacturer. Technically, the manufacturer could do nothing.<\/p>\n But since the recall classification is public, most manufacturers respond appropriately. They want to minimize negative publicity.<\/p>\n At this point, the FDA works with the manufacturer to develop a recall strategy. This strategy usually includes the point of the recall (wholesale, retail, or consumer) and a requirement for manufacturers to follow up in this area.<\/p>\n On a related note, manufacturers also have a responsibility to submit periodic recall status reports.<\/p>\n The recall strategy also includes a public release strategy. Prior to the social media era, this step was perhaps the most important one in the recall strategy process.<\/p>\n Today, however, by the time the FDA and manufacturer talk about recall strategies, the cat is already out of the bag.<\/p>\nProduct Safety Issues<\/h3>\n
\n
The Recall Recommendation Process<\/h3>\n
\n
Recall Classification<\/h3>\n
\n
Recall Strategy<\/h3>\n